BACKGROUND: Hemifacial spasm is a neuromuscular movement disorder characterized by brief or persistent involuntary contractions of the muscles innervated by the facial nerve. Its prevalence has been estimated at 11 cases per 100 000 individuals. Among the patients who were operated on by our team, the mean interval from diagnosis to surgery was 8.2 years, and more than half of them learned of the possibility of surgical treatment only through a personal search for information on the condition. These facts motivated us to write this article to raise the awareness of hemifacial spasm and its neurosurgical treatment among physicians who will encounter it. METHODS: This review article is based on a selective literature search and on our own clinical experience. RESULTS: Hemifacial spasm is usually caused by an artery compressing the facial nerve at the root exit zone of the brainstem. 85-95% of patients obtain moderate or marked relief from local injections of botulinum toxin (BTX), which must be repeated every 3 to 4 months. Alternatively, microvascular decompression has a success rate of about 85%. CONCLUSION: Local botulinum-toxin injection is a safe and well-tolerated symptomatic treatment for hemifacial spasm. In the long term, however, lasting relief can only be achieved by microvascular decompression, a microsurgical intervention with a relatively low risk and a high success rate.
BACKGROUND:Hemifacial spasm is a neuromuscular movement disorder characterized by brief or persistent involuntary contractions of the muscles innervated by the facial nerve. Its prevalence has been estimated at 11 cases per 100 000 individuals. Among the patients who were operated on by our team, the mean interval from diagnosis to surgery was 8.2 years, and more than half of them learned of the possibility of surgical treatment only through a personal search for information on the condition. These facts motivated us to write this article to raise the awareness of hemifacial spasm and its neurosurgical treatment among physicians who will encounter it. METHODS: This review article is based on a selective literature search and on our own clinical experience. RESULTS:Hemifacial spasm is usually caused by an artery compressing the facial nerve at the root exit zone of the brainstem. 85-95% of patients obtain moderate or marked relief from local injections of botulinum toxin (BTX), which must be repeated every 3 to 4 months. Alternatively, microvascular decompression has a success rate of about 85%. CONCLUSION: Local botulinum-toxin injection is a safe and well-tolerated symptomatic treatment for hemifacial spasm. In the long term, however, lasting relief can only be achieved by microvascular decompression, a microsurgical intervention with a relatively low risk and a high success rate.
Authors: Madjid Samii; Thomas Günther; Giorgio Iaconetta; Michael Muehling; Peter Vorkapic; Amir Samii Journal: Neurosurgery Date: 2002-04 Impact factor: 4.654
Authors: N Girard; M Poncet; F Caces; Y Tallon; A Chays; P Martin-Bouyer; J Magnan; C Raybaud Journal: Neuroradiology Date: 1997-01 Impact factor: 2.804
Authors: Ahmed El Damaty; Christian Rosenstengel; Marc Matthes; Joerg Baldauf; Henry W S Schroeder Journal: Neurosurg Rev Date: 2016-04-06 Impact factor: 3.042
Authors: Chenguang Guo; Hui Xu; Xuan Niu; Samuel Krimmel; Jixin Liu; Lin Gao; Ming Zhang; Yuan Wang Journal: Neuroradiology Date: 2019-12-02 Impact factor: 2.804